Nacuity Pharmaceuticals has announced that the FDA has granted Fast Track Designation to its investi...

HelpMeSee has announced new partnerships with the University of Southern California (USC)/LA General...

Glaukos has shared several promising clinical updates for its iDose sustained-release procedural pha...

Formycon, in collaboration with its licensing partner Klinge Biopharma, has announced that the Europ...

RhyGaze, a biotechnology company with headquarters in Basel, Switzerland, and Philadelphia, PA, has ...

InflammX Therapeutics, Inc. has announced an option agreement with Bausch + Lomb, granting the latte...

Ocugen has announced that the first patient in its Phase 1 clinical trial for OCU200, a potential tr...

Outlook Therapeutics has finalized the analysis of 12-week safety and efficacy data from the NORSE E...

Prevent Blindness, a leading organization dedicated to promoting eye health, announced it has receiv...

Inflammasome Therapeutics has announced encouraging 3-month topline results from a clinical trial ev...